Metraipolis › archive › dc_2efd3699feca

Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in Japan — Europe PMC PMID:40835772

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40835772
DOI: 10.1007/s10147-[numero omesso]-0
License (as archived): solo-consultazione
Archived: 2026-11-10T12:02:56.271Z
SHA-256 of the archived text: 2465e5e3a9d240c0e8a2ee701ec71c6f8785e4ad2eb7a77f784454069941f3bd
Stable URL of this page: https://metraipolis.com/documento/dc_2efd3699feca

How to cite

Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in Japan — Europe PMC PMID:40835772 — Europe PMC (en), https://europepmc.org/article/MED/40835772 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2efd3699feca (Metraipolis archive dc_2efd3699feca, sha256 2465e5e3a9d240c0e8a2ee701ec71c6f8785e4ad2eb7a77f784454069941f3bd)

BibTeX

@misc{dc2efd3699feca,
  title = {Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in Japan — Europe PMC PMID:40835772},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40835772},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2efd3699feca; sha256 2465e5e3a9d240c0e8a2ee701ec71c6f8785e4ad2eb7a77f784454069941f3bd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40835772. Agents can read the archived copy with the MCP tool read_document.